JP2024544586A5 - - Google Patents
Info
- Publication number
- JP2024544586A5 JP2024544586A5 JP2024529704A JP2024529704A JP2024544586A5 JP 2024544586 A5 JP2024544586 A5 JP 2024544586A5 JP 2024529704 A JP2024529704 A JP 2024529704A JP 2024529704 A JP2024529704 A JP 2024529704A JP 2024544586 A5 JP2024544586 A5 JP 2024544586A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- alkenyl
- haloalkenyl
- haloalkyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021903836 | 2021-11-26 | ||
| AU2021903836A AU2021903836A0 (en) | 2021-11-26 | Analogues | |
| AU2022901261 | 2022-05-12 | ||
| AU2022901261A AU2022901261A0 (en) | 2022-05-12 | Analogues | |
| PCT/AU2022/051422 WO2023092195A1 (en) | 2021-11-26 | 2022-11-28 | Analogues of mdma for modulating sert, dat, and / or net activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544586A JP2024544586A (ja) | 2024-12-03 |
| JP2024544586A5 true JP2024544586A5 (cg-RX-API-DMAC7.html) | 2025-12-03 |
Family
ID=86538463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529704A Pending JP2024544586A (ja) | 2021-11-26 | 2022-11-28 | Sert、dat、および/またはnet活性を調節するためのmdmaの類縁体 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4436964A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024544586A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022399234A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3239040A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023092195A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519816A4 (en) | 2016-09-29 | 2020-05-06 | The Regents of the University of California | CONNECTIONS FOR INCREASING NEURONAL PLASTICITY |
| KR102946120B1 (ko) | 2019-02-27 | 2026-03-30 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
| WO2022221415A2 (en) | 2021-04-13 | 2022-10-20 | The Regents Of The University Of California | Tetracyclic compounds for treating brain disorders |
| JP2025502615A (ja) | 2021-12-15 | 2025-01-28 | デリックス セラピューティクス,インク. | フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005154350A (ja) * | 2003-11-26 | 2005-06-16 | Japan Science & Technology Agency | 不斉アリルアミンの合成方法 |
| AU2004309067B2 (en) * | 2003-12-23 | 2009-12-17 | Basf Aktiengesellschaft | 1-(azolin-2-yl) amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes |
-
2022
- 2022-11-28 JP JP2024529704A patent/JP2024544586A/ja active Pending
- 2022-11-28 WO PCT/AU2022/051422 patent/WO2023092195A1/en not_active Ceased
- 2022-11-28 EP EP22896885.5A patent/EP4436964A4/en active Pending
- 2022-11-28 AU AU2022399234A patent/AU2022399234A1/en active Pending
- 2022-11-28 CA CA3239040A patent/CA3239040A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Forrer et al. | Experimental physiological studies with lysergic acid diethylamide (LSD-25) | |
| CN1206996C (zh) | 用于治疗或预防睡眠障碍的药物组合物 | |
| CN105143190A (zh) | 作为mao抑制剂的被取代的萘啶和喹啉化合物 | |
| JP2002535408A5 (cg-RX-API-DMAC7.html) | ||
| JP2024521747A5 (cg-RX-API-DMAC7.html) | ||
| JP2004534065A (ja) | 疾患治療用のキヌクリジン置換二環系へテロ芳香族化合物 | |
| WO2022261263A1 (en) | Methods of treating neuropsychiatric disorders | |
| CN1160360C (zh) | 用于增强突触应答的氧氮杂萘化合物 | |
| US7566725B2 (en) | Imidazo[1,2-A] pyridine anxiolytics | |
| JP2019511548A5 (cg-RX-API-DMAC7.html) | ||
| EP4436964A1 (en) | Analogues of mdma for modulating sert, dat, and / or net activity | |
| WO2017007755A1 (en) | Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase | |
| WO2025010308A2 (en) | Mdma enantiomer compositions and methods for modulating aggression response | |
| JP2025530256A (ja) | ストレス関連障害の治療のためのmdmaの使用 | |
| WO2019220138A1 (en) | Ketamine derivatives to treat neurological or psychological diseases | |
| CN1186020C (zh) | 用于提高突触应答的酰基苯并噁嗪 | |
| Sandyk | A drug naive parkinsonian patient successfully treated with weak electromagnetic fields | |
| US20250333371A1 (en) | Compounds | |
| AU2003302911A1 (en) | Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compostions and preparations thereof | |
| WO2022217247A1 (en) | Isochroman derivatives and compositions and uses thereof | |
| JP2015524456A (ja) | ピペラジノ[1,2−a]インドール−1−オン類及び[1,4]ジアゼピノ[1,2−a]インドール−1−オン | |
| TWI404542B (zh) | 用於治療抽動症及具有感覺運動門控不良之精神疾病的海州常山屬組合物 | |
| CN1306532A (zh) | 新的吡咯并(3,4-b)喹啉衍生物,其制备方法及其作为药物的用途 | |
| JP2008524236A5 (cg-RX-API-DMAC7.html) | ||
| WO2004099202A1 (en) | Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases |